These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33682222)

  • 1. Salivary BPIFA proteins are altered in patients undergoing hematopoietic cell transplantation.
    Innocentini LMAR; Silva AA; Carvalho MA; Coletta RD; Corrêa MEP; Bingle L; Bingle CD; Vargas PA; Lopes MA
    Oral Dis; 2022 May; 28(4):1279-1288. PubMed ID: 33682222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study.
    Bulthuis MS; van Leeuwen SJM; Thomas RZ; van Gennip LLA; Whiteside HM; Isom S; Kline DM; Laheij AMGA; Raber-Durlacher JE; Hasséus B; Johansson JE; Hovan AJ; Brennan MT; von Bültzingslöwen I; Huysmans MDNJM; Blijlevens NMA
    Transplant Cell Ther; 2024 Apr; 30(4):446.e1-446.e11. PubMed ID: 38242439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study.
    Bulthuis MS; van Gennip LLA; Thomas RZ; Bronkhorst EM; Laheij AMGA; Raber-Durlacher JE; Rozema FR; Brennan MT; von Bültzingslöwen I; Blijlevens NMA; Huysmans MDNJM; van Leeuwen SJM
    Clin Oral Investig; 2023 Dec; 27(12):7369-7381. PubMed ID: 37853264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary BPIFA1 (SPLUNC1) and BPIFA2 (SPLUNC2 A) are modified by head and neck cancer radiotherapy.
    González-Arriagada WA; Ramos LM; Silva AA; Vargas PA; Coletta RD; Bingle L; Lopes MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):48-58. PubMed ID: 25482547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary antioxidant enzymes associated with oral toxicity in haematopoietic cell transplantation: An observational study.
    Bezinelli LM; Eduardo FP; Ferreira MH; Gobbi M; Lopes RMG; Rosin FCP; Vogel C; Hamerschlak N; Corrêa L
    Eur J Clin Invest; 2021 Feb; 51(2):e13379. PubMed ID: 32959899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.
    Imanguli MM; Atkinson JC; Harvey KE; Hoehn GT; Ryu OH; Wu T; Kingman A; Barrett AJ; Bishop MR; Childs RW; Fowler DH; Pavletic SZ; Hart TC
    Exp Hematol; 2007 Feb; 35(2):184-92. PubMed ID: 17258067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
    Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
    Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
    Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
    Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model.
    Levy S; Nagler A; Okon S; Marmary Y
    Bone Marrow Transplant; 2000 May; 25(10):1073-8. PubMed ID: 10828868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
    DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease.
    Bassim CW; Ambatipudi KS; Mays JW; Edwards DA; Swatkoski S; Fassil H; Baird K; Gucek M; Melvin JE; Pavletic SZ
    J Clin Immunol; 2012 Dec; 32(6):1390-9. PubMed ID: 22806177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
    Chhabra S; Ahn KW; Hu ZH; Jain S; Assal A; Cerny J; Copelan EA; Daly A; DeFilipp Z; Gadalla SM; Gale RP; Ganguly S; Hamilton BK; Hildebrandt GC; Hsu JW; Inamoto Y; Kanate AS; Khoury HJ; Lazarus HM; Litzow MR; Nathan S; Olsson RF; Pawarode A; Ringden O; Rowe JM; Saad A; Savani BN; Schouten HC; Seo S; Shah NN; Solh M; Stuart RK; Ustun C; Woolfrey AE; Yared JA; Alyea EP; Kalaycio ME; Popat U; Sobecks RM; Saber W
    Blood Adv; 2018 Nov; 2(21):2922-2936. PubMed ID: 30396912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
    Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
    Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The parotid secretory protein BPIFA2 is a salivary surfactant that affects lipopolysaccharide action.
    Nandula SR; Huxford I; Wheeler TT; Aparicio C; Gorr SU
    Exp Physiol; 2020 Aug; 105(8):1280-1292. PubMed ID: 32390232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.
    Boer CC; Correa ME; Tenuta LM; Souza CA; Vigorito AC
    Support Care Cancer; 2015 Sep; 23(9):2561-7. PubMed ID: 25652148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation.
    Zhang H
    Transfus Apher Sci; 2020 Jun; 59(3):102743. PubMed ID: 32139282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis.
    Bachier CR; Aggarwal SK; Hennegan K; Milgroom A; Francis K; Dehipawala S; Rotta M
    Transplant Cell Ther; 2021 Jun; 27(6):504.e1-504.e6. PubMed ID: 34158154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.